Cargando…
Epstein–Barr Virus-Specific Immune Control by Innate Lymphocytes
Epstein–Barr virus (EBV) is a potent B cell transforming pathogen in humans. In most persistently EBV-infected individuals, potent cytotoxic lymphocyte responses prevent EBV-associated pathologies. In addition to comprehensive adaptive T cell responses, several innate lymphocyte populations seem to...
Autor principal: | Münz, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705607/ https://www.ncbi.nlm.nih.gov/pubmed/29225606 http://dx.doi.org/10.3389/fimmu.2017.01658 |
Ejemplares similares
-
NK Cell Influence on the Outcome of Primary Epstein–Barr Virus Infection
por: Chijioke, Obinna, et al.
Publicado: (2016) -
Immune Control and Vaccination against the Epstein–Barr Virus in Humanized Mice
por: Münz, Christian
Publicado: (2019) -
Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection
por: Münz, Christian
Publicado: (2021) -
Immune Escape by Non-coding RNAs of the Epstein Barr Virus
por: Münz, Christian
Publicado: (2021) -
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
por: Bickham, Kara, et al.
Publicado: (2003)